Fair Participant Selection: A Negative Obligation Not to Exclude.

The trial in question is testing the safety and efficacy of insulin-like growth factor 1 (IGF-1) in patients with Phelan–McDermid syndrome (PMS). To participate, patients must remain in close proxi...